Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06835920 · ClinicalTrials.gov registry record · NA

Alcohol Labeling Study

A NA study of Health Behavior, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
720
Enrollment target
2
Study locations

NCT06835920: Recruiting NA study of Health Behavior, sponsored by University of North Carolina, Chapel Hill.

NCT06835920 is a NA study of Health Behavior that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 720 participants, below the 2,175-participant average among 65 other Health Behavior trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06835920, a NA study of Health Behavior, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
720 participants
Enrollment target
2
Study locations

Study Summary

This study aims to examine the effects of new front-of-package alcohol warnings on alcohol consumption. Participants will be randomly assigned to either new front-of-package health warnings or control labels. Participants will bring in their own alcohol to weekly study visits and take home the alcohol to consume as usual. Participants will receive study labels on their alcohol containers per their assigned trial arm.

Primary Outcome

Measured using the following item "How many drinks did you have yesterday? If you're not sure, make your best guess. By 'yesterday,' we mean before you went to bed, even if the drinking happened after midnight. One drink is equivalent to a 12-ounce beer, a 5-ounce glass of wine, or a drink with one shot of liquor." Participants will respond with the number of drinks they consumed.

Conditions Studied

Interventions

  • BEHAVIORAL Control label
  • BEHAVIORAL Front-of-package health warning

Study Locations (2)

North Carolina

  • UNC study office - Chapel Hill
  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2025-04-28
Est. Completion 2026-08
Phase NA

What NCT06835920 shows while recruiting

NCT06835920 is an interventional study that assigns participants to a tested intervention. The registered 720 participants enrollment target is mid-sized for trials with a published cap, below the 2,175-participant average among 65 other Health Behavior trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which Control label is the first listed.

NCT06835920 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06835920 about?

NCT06835920 is a clinical study titled "Alcohol Labeling Study". This study aims to examine the effects of new front-of-package alcohol warnings on alcohol consumption. Participants will be randomly assigned to either new front-of-package health warnings or control labels. Participants will bring in their own alcohol to weekly study visits and take home the alcoh...

What is the current status of trial NCT06835920?

This trial is currently recruiting. It is a NA study. The enrollment target is 720 participants. The study started on 2025-04-28. Estimated completion is 2026-08.

What conditions does trial NCT06835920 study?

This clinical trial studies the following conditions: Health Behavior.

What interventions are being tested in trial NCT06835920?

The interventions under investigation include: Control label (BEHAVIORAL), Front-of-package health warning (BEHAVIORAL).

Who is sponsoring clinical trial NCT06835920?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06835920 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06835920's enrollment target sits among peer trials

720 16th of 65 higher than 50 of 65 other Health Behavior trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04916327 · 720 participants · NA

    Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

  • NCT05047224 · 720 participants · NA

    Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

  • NCT05309395 · 720 participants · Phase 3

    Food Prescriptions to Promote Affordable Diets

  • NCT05466214 · 720 participants · NA

    Systematic Efficacy Replication Study of Conjoint Behavioral Consultation in Elementary Schools

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06835920, the US trial registry maintained by the National Library of Medicine. NCT06835920 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.